Clinical Trial Update: Prostatic Size Reduction Following of Leuprorelin Acetate

View source ↗

Summary

A clinical trial is currently recruiting to assess prostatic size reduction following treatment with leuprorelin acetate in men with prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Leuprorelin acetate (Leuprorelin acetate)

Snippet

Sponsor: Consorci Sanitari de Terrassa | Conditions: Prostate Cancer Adenocarcinoma, Prostate Adenocarcinoma | Status: RECRUITING